Pre-symptomatic diagnosis in ALS.

Area of Science:

• Neuroscience
• Genetics
• Medical Research

Background:

• Amyotrophic lateral sclerosis (ALS) pathophysiology involves multifactorial processes with varying genetic influences.
• Familial ALS (fALS) accounts for 10% of cases, while sporadic ALS (sALS) comprises 90%, though clinical distinction is challenging.
• Over 30 genes are linked to fALS, with C9ORF72, SOD1, TARDBP, FUS, and TBK1 being predominant.

Purpose of the Study:

• To address the increasing need for genetic risk assessment in relatives of ALS patients.
• To propose a framework for pre-symptomatic genetic testing in individuals at risk for ALS.
• To highlight the complexities in diagnosing familial ALS due to potential misclassification.

Main Methods:

• Review of genetic factors implicated in amyotrophic lateral sclerosis (ALS).
• Analysis of mutation frequencies in predominant ALS-associated genes (C9ORF72, SOD1, TARDBP, FUS, TBK1).
• Discussion of challenges in identifying familial ALS and the rationale for genetic screening.

Main Results:

• Significant advancements in genetic research have identified numerous ALS-related gene mutations.
• Easier access to genetic testing has increased inquiries from at-risk relatives.
• Pre-symptomatic testing for ALS is becoming a common practice in clinical settings.

Conclusions:

• A structured framework for pre-symptomatic genetic testing is necessary for individuals at risk of developing ALS.
• Familial history alone is insufficient for accurate ALS classification, necessitating genetic evaluation.
• Genetic counseling and testing are vital for managing familial ALS and informing at-risk individuals.